Resilience Intervention for Older, HIV-Infected Women

Status Completed

Clinical Trial Summary

The goal of this study is to refine and pilot the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and living with chronic disease. The investigators will adapt the 3RP resiliency intervention to the needs of this population and conduct preliminary testing of the group intervention via an open pilot study.

Clinical Trial Description

Overview.

Participants will be women living with HIV (N=up to 40) age 50 or over. Women will be recruited from the Boston area. Based on the investigators' qualitative work, the investigators will deliver an adapted version of the 3RP resiliency intervention to groups of 5-8 HIV-infected women age 50 and over. The 3RP intervention will consist of 8-10 weekly sessions of 90 minutes each focused on skills training to build and enhance resilience. The investigators will conduct baseline and post-treatment quantitative assessments, in addition to individual exit interviews to solicit feedback on the intervention. These data will be used to inform the design of a future randomized pilot study.

Study procedures.

Participants (N = up to 40) will be HIV-infected women age 50 or over . Participants will be recruited via study flyers (posted in the infectious disease clinics at local hospitals and in the waiting areas of Boston area community organizations) and provider referral. Once an individual expresses interest in the study, a research assistant will screen that individual to assess study eligibility criteria. Individuals who meet inclusion criteria will be invited to sign informed consent and complete an in-person baseline assessment. Participants will then complete the intervention (described below), a post-treatment assessment, and an individual in-depth exit interview to provide feedback on their experience in the study.

3RP Intervention:

Once enrolled in the study, participants will complete weekly group sessions of the 3RP intervention. Sessions will focus on developing an understanding of stress sources and physiology, and on developing a regular practice of eliciting the relaxation response (RR) and learning cognitive behavioral and positive psychology skills to enhance resiliency to long-term stress. Participants will be encouraged to practice skills (RR practice, thoughts records to learn adaptive thinking) between group sessions. ;

Study Design

Related Conditions & MeSH terms

Resilience, Psychological

Clinical Trial Details

NCT number	NCT03071887
Study type	Interventional
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	N/A
Start date	November 27, 2017
Completion date	August 27, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03270943` - The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens	N/A
Terminated	`NCT04970641` - Three Good Things (3GT) - Intervention for Transitional Care Patients	N/A
Completed	`NCT03308981` - Efficacy of the REThink Therapeutic Online Game	N/A
Active, not recruiting	`NCT05293431` - Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic	N/A
Recruiting	`NCT05072340` - Evaluation of Resilience Skills Enhancement (RISE) Training Among University Students	N/A
Recruiting	`NCT05094115` - Enhancing Resiliency and Optimizing Readiness in Military Personnel	N/A
Not yet recruiting	`NCT06061965` - Facilitating Advance Care Planning Discussions for People With Advance Cancer	N/A
Completed	`NCT03673098` - The BRIgHT Program: Building Resilience in HIV Together	N/A
Active, not recruiting	`NCT05719129` - The Lasting Change Study
Recruiting	`NCT05130879` - Building Resilience @ Work Training Among Healthcare Workers	N/A
Active, not recruiting	`NCT03705208` - Youth First: A Longitudinal Impact Evaluation	N/A
Completed	`NCT05703529` - Group-based Positive Psychotherapy in Psychological Resilience of Only-Child-Lost People	N/A
Completed	`NCT02603133` - Web-based Implementation for the Science of Enhancing Resilience Study	N/A
Completed	`NCT05133115` - Fostering Resilience in Adolescents at Risk.	N/A
Recruiting	`NCT04935710` - Prevention and Early Identification for High Risk Youth in School-based Clinics	Phase 1
Completed	`NCT04231604` - Evaluation of a School-based Programme Aimed at Promoting Well-being in Adolescents	N/A
Enrolling by invitation	`NCT06021236` - Efficacy of a Mindfulness-Based Intervention in Patients With Cardiovascular Implantable Electronic Device	N/A
Recruiting	`NCT03458936` - Resilience in Adolescent Development
Completed	`NCT05154565` - Effect of a Daily Meditation Intervention in Student Pharmacists	N/A
Completed	`NCT02908932` - Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Resilience Intervention for Older, HIV-Infected Women — BRIgHT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms